Pieter van Rooyen is CEO of Edico Genome, one of 17 companies in the Qualcomm Life Fund investment portfolio. Van Rooyen is holding the company’s specialized microchip called Dragen that performs next-generation sequencing of a genome.

Pieter van Rooyen is CEO of Edico Genome, one of 17 companies in the Qualcomm Life Fund investment portfolio. Van Rooyen is holding the company’s specialized microchip called Dragen that performs next-generation sequencing of a genome. Photo by Stephen Whalen.

Qualcomm Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129